category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,Annotation,ontology
ARA:PWY-5064,2.9954207799456374e-4,1,2,2,chlorophyll a biosynthesis II,BioCyc
ARA:PWY-6051,3.4357497374137933e-4,0.999992116739151,3,8,"2,4,6-trinitrotoluene degradation",BioCyc
ARA:SULFMETII-PWY,4.660116424671624e-4,0.9999875587795269,3,9,sulfate reduction II (assimilatory),BioCyc
ARA:PWY-6348,0.001669743519595849,0.9998579788861947,4,27,phosphate acquisition,BioCyc
ARA:PWY-5320,0.0033750070312950774,0.9997932111558107,3,16,kaempferol glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-5068,0.003727314934129813,0.9999212695050257,2,6,chlorophyll cycle,BioCyc
ARA:PWY-5079,0.008238101527865187,0.999712562657934,2,8,L-phenylalanine degradation III,BioCyc
ARA:PWY-5272,0.013709012384307454,0.9993579137379457,2,9,abscisic acid glucose ester metabolism,BioCyc
ARA:PWY-5086,0.015808518020774456,1,1,1,chlorophyll a biosynthesis I,BioCyc
ARA:PWY-5063,0.019068132567699153,1,1,1,phytyl diphosphate biosynthesis,BioCyc
ARA:PWY-6239,0.01932424606941632,1,1,1,luteolin glycosides biosynthesis,BioCyc
ARA:PWY-321,0.020119936038298796,0.9974444774548183,3,35,cutin biosynthesis,BioCyc
ARA:PWY-5859,0.02054378612774807,0.9987619019111603,2,11,eugenol and isoeugenol biosynthesis,BioCyc
ARA:PWY-5486,0.031906410853656746,0.9974427366974081,2,16,pyruvate fermentation to ethanol II,BioCyc
ARA:PWY-6890,0.03266160811689112,0.9997330347255585,1,2,4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis,BioCyc
ARA:PWY-5271,0.03558325498944365,0.9996826545755777,1,2,phaseic acid biosynthesis,BioCyc
ARA:PWY-7640,0.03558325498944365,0.9996826545755777,1,2,neophaseic acid biosynthesis,BioCyc
ARA:PWY-5321,0.05834374166862239,0.9886507234186701,3,44,quercetin glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-6266,0.05834374166862239,0.9886507234186701,3,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6266-ARA,0.05834374166862239,0.9886507234186701,3,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-5667,0.06838049839499341,0.9913645474865215,2,25,CDP-diacylglycerol biosynthesis I,BioCyc
ARA:PWY-101,0.07100050057517539,0.9850114908834458,3,46,photosynthesis light reactions,BioCyc
ARA:PWY-6930,0.08024876781625048,0.9975382642974286,1,4,phenolic malonylglucosides biosynthesis,BioCyc
ARA:PWY-3941,0.08904612431679508,0.9967591266317521,1,5,&beta;-alanine biosynthesis II,BioCyc
ARA:PWY-2261,0.08931102331637193,0.9868475668836452,2,26,ascorbate glutathione cycle,BioCyc
ARA:PHOTOALL-PWY,0.08948171888972471,0.9733717045314636,4,85,oxygenic photosynthesis,BioCyc
ARA:PWY-5807,0.09688132230507224,0.9961506113751636,1,5,heptaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-6014,0.09706146494387212,0.9961359792498996,1,5,vernolate biosynthesis I,BioCyc
ARA:PWY-6710,0.09706146494387212,0.9961359792498996,1,5,poly-hydroxy fatty acids biosynthesis,BioCyc
ARA:TRIGLSYN-PWY,0.09785919581021674,0.9761144679058441,3,66,diacylglycerol and triacylglycerol biosynthesis,BioCyc
ARA:PWY-6803,0.10260742562917083,0.9744565687917452,3,65,phosphatidylcholine acyl editing,BioCyc
ARA:PWY-5670,0.10456268171537271,0.9951897688342018,1,7,epoxysqualene biosynthesis,BioCyc
ARA:PWY4FS-8,0.10887040719982857,0.981839568023782,2,32,phosphatidylglycerol biosynthesis II (non-plastidic),BioCyc
ARA:PWY-6773,0.11174360041317756,0.9939316511757139,1,19,"1,3-&beta;-D-glucan biosynthesis",BioCyc
ARA:PWY0-1313,0.1236845661066059,0.9928894943924127,1,10,acetate conversion to acetyl-CoA,BioCyc
ARA:PWY-5098,0.12726415322360052,0.9928059067573962,1,7,chlorophyll a degradation I,BioCyc
ARA:PWY-5203,0.128769102452884,0.9923682880250868,1,9,soybean saponin I biosynthesis,BioCyc
ARA:PWYQT-4476,0.13803829274786072,0.9913278296456828,1,8,indole glucosinolate activation (herbivore attack),BioCyc
ARA:PWY-5791,0.14139748999257515,0.9907496271599399,1,9,"1,4-dihydroxy-2-naphthoate biosynthesis II (plants)",BioCyc
ARA:PWY-5837,0.14139748999257515,0.9907496271599399,1,9,"1,4-dihydroxy-2-naphthoate biosynthesis",BioCyc
ARA:PWY-6163,0.1465132219915005,0.9900468994183054,1,9,chorismate biosynthesis from 3-dehydroquinate,BioCyc
ARA:PWY-861,0.14940421209954696,0.9897919144092138,1,8,dhurrin biosynthesis,BioCyc
ARA:PWY-5267,0.15576927761082585,0.9887057171333115,1,9,glucosinolate activation,BioCyc
ARA:GLYSYN-PWY,0.16408737766621945,0.9871527692949187,1,11,glycine biosynthesis I,BioCyc
ARA:PWY-6936,0.17059481866512413,0.9862071552995896,1,10,seleno-amino acid biosynthesis,BioCyc
ARA:PWY-2541,0.17227534686820212,0.9617931836248118,2,44,plant sterol biosynthesis,BioCyc
ARA:PWY-5080,0.17563350585588064,0.960670747258917,2,41,very long chain fatty acid biosynthesis I,BioCyc
ARA:GLYSYN-ALA-PWY,0.1833870418715608,0.9836957851672408,1,12,glycine biosynthesis III,BioCyc
ARA:PWY-5084,0.21768803555998684,0.976296156240077,1,15,2-oxoglutarate decarboxylation to succinyl-CoA,BioCyc
ARA:LIPAS-PWY,0.2183283869440892,0.9232424797253814,3,93,triacylglycerol degradation,BioCyc
ARA:PWY-5143,0.21833213264629187,0.9759641306267496,1,17,long-chain fatty acid activation,BioCyc
ARA:PWY-2161,0.219547349455945,0.9757709936376251,1,16,folate polyglutamylation,BioCyc
ARA:PWY-6927,0.2268026248913752,0.9742905976408704,1,14,chlorophyll a degradation II,BioCyc
ARA:PWY-5453,0.23867204017178204,0.9715377263304136,1,13,methylglyoxal degradation III,BioCyc
ARA:PWY-1782,0.2410110075894951,0.9706520855907017,1,15,superpathway of indole-3-acetate conjugate biosynthesis,BioCyc
ARA:HISTSYN-PWY,0.24815261545935954,0.9686631292372478,1,16,L-histidine biosynthesis,BioCyc
ARA:PWY-6663,0.25086730817783165,0.9676288709272478,1,19,plant sterol biosynthesis II,BioCyc
ARA:PWY-7204,0.2551479806724079,0.9667701833216422,1,16,pyridoxal 5'-phosphate salvage II (plants),BioCyc
ARA:GLYCLEAV-PWY,0.25605270758466864,0.9664016339333219,1,17,glycine cleavage,BioCyc
ARA:PWY-5046,0.25605906266122896,0.9663998729276312,1,17,2-oxoisovalerate decarboxylation to isobutanoyl-CoA,BioCyc
ARA:PWY-6786,0.26309637192716434,0.9646867502495767,1,15,detoxification of reactive carbonyls in chloroplasts,BioCyc
ARA:GLYSYN2-PWY,0.27878329389851697,0.9594318530266223,1,20,glycine biosynthesis,BioCyc
ARA:ILEUDEG-PWY,0.2945983665041282,0.9543788338182864,1,20,L-isoleucine degradation I,BioCyc
ARA:PYRUVDEHYD-PWY,0.31276727609276295,0.9479354458394478,1,22,pyruvate decarboxylation to acetyl CoA,BioCyc
ARA:TRPSYN-PWY,0.3260211488718162,0.9430862641569357,1,22,L-tryptophan biosynthesis,BioCyc
ARA:CHLOROPHYLL-SYN,0.3291105286250437,0.9419200864271944,1,22,"3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)",BioCyc
ARA:LIPASYN-PWY,0.34329604216638654,0.8798521079227184,2,72,phospholipases,BioCyc
ARA:CYSTSYN-PWY,0.37527706347755274,0.9224464735266292,1,25,L-cysteine biosynthesis I,BioCyc
ARA:PWY-5147,0.38335876555159776,0.918276298479536,1,30,oleate biosynthesis I (plants),BioCyc
ARA:VALDEG-PWY,0.3986592417409795,0.9109663201485866,1,30,L-valine degradation I,BioCyc
ARA:PWY66-21,0.40975767193794727,0.9051065790908734,1,34,ethanol degradation II,BioCyc
ARA:LEU-DEG2-PWY,0.42089071261773603,0.8994859143045573,1,32,L-leucine degradation I,BioCyc
ARA:PWY-7036,0.4268134494000462,0.8964199858272548,1,31,very long chain fatty acid biosynthesis II,BioCyc
ARA:PWY-581,0.4296613707558728,0.8948827560830079,1,31,indole-3-acetate biosynthesis II,BioCyc
ARA:ETHYL-PWY,0.44130909634186466,0.8884499799833538,1,31,ethylene biosynthesis I (plants),BioCyc
ARA:PWY-6842,0.4433062720948675,0.813629393302368,2,71,glutathione-mediated detoxification II,BioCyc
ARA:PWY-181,0.4741591929154783,0.8685230917212676,1,36,photorespiration,BioCyc
ARA:PWY-6733,0.475427756846904,0.8674979000462848,1,39,sporopollenin precursors biosynthesis,BioCyc
ARA:PWY-3841,0.48248465807050045,0.8631006237383935,1,38,folate transformations II,BioCyc
ARA:COMPLETE-ARO-ARA-PWY,0.5013748418474938,0.8506630799889446,1,38,"superpathway of phenylalanine, tyrosine and tryptophan biosynthesis",BioCyc
ARA:PWY-5989,0.5066082232526496,0.8468573837113857,1,41,stearate biosynthesis II (bacteria and plants),BioCyc
ARA:SUCSYN-PWY,0.5067242928774507,0.8468522974879993,1,40,sucrose biosynthesis I (from photosynthesis),BioCyc
ARA:PWY-5971,0.5227599064532797,0.8353305795461685,1,43,palmitate biosynthesis II (bacteria and plants),BioCyc
ARA:CALVIN-PWY,0.527656486505442,0.8320880614004478,1,39,Calvin-Benson-Bassham cycle,BioCyc
ARA:PWY-5381,0.5356932363248286,0.8260603122968861,1,40,pyridine nucleotide cycling (plants),BioCyc
ARA:PWY-1121,0.6073069864559649,0.7655986893420652,1,54,suberin monomers biosynthesis,BioCyc
ARA:PWY-1042,0.6152841923719391,0.7581379250918729,1,55,glycolysis IV (plant cytosol),BioCyc
ARA:GLUCONEO-PWY,0.6463271122476546,0.7274346896371441,1,60,gluconeogenesis I,BioCyc
ARA:PWYQT-4471,0.6625181607986497,0.7108587932409351,1,54,glucosinolate biosynthesis from dihomomethionine,BioCyc
ARA:PWY66-399,0.6722190319842402,0.6998595618208516,1,62,gluconeogenesis III,BioCyc
ARA:PWY-5484,0.6780137668896047,0.693382910138455,1,63,glycolysis II (from fructose 6-phosphate),BioCyc
ARA:PWY-401,0.9999999999999932,0.867459646661129,0,9,galactolipid biosynthesis I,BioCyc
ARA:PWY-6607,0.9999999999999959,0.7996592676701494,0,15,guanosine nucleotides degradation I,BioCyc
ARA:PWY-3781,0.9999999999999996,0.12015044582611462,0,104,aerobic respiration I (cytochrome c),BioCyc
ARA:ALACAT2-PWY,1,0.8163604490673765,0,12,L-alanine degradation II (to D-lactate),BioCyc
ARA:ALANINE-DEG3-PWY,1,0.879861299256754,0,8,L-alanine degradation III,BioCyc
ARA:ALANINE-SYN2-PWY,1,0.879861299256754,0,8,L-alanine biosynthesis II,BioCyc
ARA:ARG-PRO-PWY,1,0.9267837847321989,0,4,L-arginine degradation VI (arginase 2 pathway),BioCyc
ARA:ARGASEDEG-PWY,1,0.9531797943933449,0,3,L-arginine degradation I (arginase pathway),BioCyc
ARA:ARGDEG-V-PWY,1,0.95059886397243,0,3,L-arginine degradation X (arginine monooxygenase pathway),BioCyc
ARA:ARGININE-SYN4-PWY,1,0.9036439225708837,0,6,L-ornithine biosynthesis II,BioCyc
ARA:ARGSPECAT-PWY,1,0.807680947122724,0,11,spermine biosynthesis,BioCyc
ARA:ARGSYN-PWY,1,0.7504359187973234,0,16,L-arginine biosynthesis I (via L-ornithine),BioCyc
ARA:ARGSYNBSUB-PWY,1,0.7647216616895655,0,15,L-arginine biosynthesis II (acetyl cycle),BioCyc
ARA:ASPARAGINE-BIOSYNTHESIS,1,0.9144328578013097,0,6,L-asparagine biosynthesis I,BioCyc
ARA:ASPARAGINE-DEG1-PWY,1,0.8872669851558073,0,6,L-asparagine degradation I,BioCyc
ARA:ASPARAGINESYN-PWY,1,0.9144328578013097,0,6,L-asparagine biosynthesis II,BioCyc
ARA:ASPARTATE-DEG1-PWY,1,0.7999731969568816,0,14,L-aspartate degradation I,BioCyc
ARA:ASPARTATESYN-PWY,1,0.7999731969568816,0,14,L-aspartate biosynthesis,BioCyc
ARA:ASPASN-ARA-PWY,1,0.6484798848663069,0,26,superpathway of aspartate and asparagine biosynthesis,BioCyc
ARA:ASPSYNII-PWY,1,0.8307798781385409,0,10,cyanide detoxification I,BioCyc
ARA:BRANCHED-CHAIN-AA-SYN-PWY,1,0.5448458273538269,0,37,superpathway of branched chain amino acid biosynthesis,BioCyc
ARA:BSUBPOLYAMSYN-PWY,1,0.7927286026116033,0,12,spermidine biosynthesis I,BioCyc
ARA:CAMALEXIN-SYN,1,0.5696347916700231,0,29,camalexin biosynthesis,BioCyc
ARA:CITRULBIO-PWY,1,0.5850477176412031,0,35,L-citrulline biosynthesis,BioCyc
ARA:CITRULLINE-DEG-PWY,1,0.9805078936092086,0,1,L-citrulline degradation,BioCyc
ARA:COA-PWY,1,0.8317408373353353,0,9,coenzyme A biosynthesis I,BioCyc
ARA:CYANCAT-PWY,1,0.940105267126458,0,3,cyanate degradation,BioCyc
ARA:DETOX1-PWY,1,0.6861681675448777,0,21,superoxide radicals degradation,BioCyc
ARA:DETOX1-PWY-1,1,0.590554068200726,0,28,reactive oxygen species degradation,BioCyc
ARA:ETOH-ACETYLCOA-ANA-PWY,1,0.8076705214385764,0,12,ethanol degradation I,BioCyc
ARA:FASYN-ELONG-PWY,1,0.7498369871855814,0,15,fatty acid elongation -- saturated,BioCyc
ARA:GLNSYN-PWY,1,0.839765187818413,0,10,L-glutamine biosynthesis I,BioCyc
ARA:GLUCOSE1PMETAB-PWY,1,0.741905205086654,0,21,glucose and glucose-1-phosphate degradation,BioCyc
ARA:GLUGLNSYN-PWY,1,0.9810285199204024,0,3,L-glutamate biosynthesis IV,BioCyc
ARA:GLUT-REDOX-PWY,1,0.9524400108961986,0,4,glutathione-glutaredoxin redox reactions,BioCyc
ARA:GLUTAMATE-DEG1-PWY,1,0.9279654569387447,0,4,L-glutamate degradation I,BioCyc
ARA:GLUTAMATE-SYN2-PWY,1,0.9279654569387447,0,4,L-glutamate biosynthesis II,BioCyc
ARA:GLUTAMINDEG-PWY,1,0.6584190258558613,0,28,L-glutamine degradation I,BioCyc
ARA:GLUTATHIONESYN-PWY,1,0.9591737926090734,0,3,glutathione biosynthesis,BioCyc
ARA:GLUTORN-PWY,1,0.8168585423717359,0,11,L-ornithine biosynthesis I,BioCyc
ARA:GLUTSYNIII-PWY,1,0.9088297840570373,0,6,L-glutamate biosynthesis III,BioCyc
ARA:GLYCOLYSIS,1,0.36986613156721926,0,57,glycolysis I (from glucose 6-phosphate),BioCyc
ARA:GLYOXDEG-PWY,1,0.9723165103443026,0,2,glycolate and glyoxylate degradation II,BioCyc
ARA:GLYOXYLATE-BYPASS,1,0.7598375546171842,0,17,glyoxylate cycle,BioCyc
ARA:HEME-BIOSYNTHESIS-II,1,0.7876532570075523,0,14,heme biosynthesis I (aerobic),BioCyc
ARA:HEXPPSYN-PWY,1,0.9633610260360889,0,2,hexaprenyl diphosphate biosynthesis,BioCyc
ARA:HOMOCYSDEGR-PWY,1,0.9815440545144678,0,1,L-cysteine biosynthesis III (from L-homocysteine),BioCyc
ARA:HOMOSER-THRESYN-PWY,1,0.9195397116376051,0,4,L-threonine biosynthesis,BioCyc
ARA:HOMOSERSYN-PWY,1,0.8744810992375347,0,10,L-homoserine biosynthesis,BioCyc
ARA:ILE-VAL-PWY,1,0.7505218692695989,0,19,superpathway of isoleucine and valine biosynthesis,BioCyc
ARA:ILEUSYN-PWY,1,0.8277976243437092,0,12,L-isoleucine biosynthesis I (from threonine),BioCyc
ARA:KDOSYN-PWY,1,0.965533157801779,0,2,Kdo transfer to lipid IVA I,BioCyc
ARA:LCYSDEG-PWY,1,0.9798824977225663,0,1,L-cysteine degradation II,BioCyc
ARA:LEUSYN-PWY,1,0.631388944526363,0,27,L-leucine biosynthesis,BioCyc
ARA:LYSINE-DEG2-PWY,1,0.835259281478326,0,12,lysine degradation II,BioCyc
ARA:MALATE-ASPARTATE-SHUTTLE-PWY,1,0.7002089711247458,0,21,L-aspartate degradation II,BioCyc
ARA:MANNCAT-PWY,1,0.9280656455413769,0,4,D-mannose degradation,BioCyc
ARA:MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS,1,0.6357968711106254,0,25,"protein N-glycosylation (eukaryotic, high mannose)",BioCyc
ARA:METHIONINE-DEG1-PWY,1,0.8381292416882431,0,9,L-methionine degradation I (to L-homocysteine),BioCyc
ARA:NAGLIPASYN-PWY,1,0.8083379222166244,0,11,lipid IVA biosynthesis,BioCyc
ARA:NONMEVIPP-PWY,1,0.7770169587954302,0,15,methylerythritol phosphate pathway I,BioCyc
ARA:NONOXIPENT-PWY,1,0.7449262641941076,0,16,pentose phosphate pathway (non-oxidative branch),BioCyc
ARA:OXIDATIVEPENT-PWY,1,0.6973586617285241,0,20,pentose phosphate pathway (oxidative branch) I,BioCyc
ARA:P401-PWY,1,0.8452545774070719,0,9,cyanide degradation,BioCyc
ARA:PANTO-PWY,1,0.8909886525794077,0,7,phosphopantothenate biosynthesis I,BioCyc
ARA:PENTOSE-P-PWY,1,0.5186291920306988,0,36,pentose phosphate pathway,BioCyc
ARA:PHOSLIPSYN2-PWY,1,0.9066040671596455,0,6,superpathway of phospholipid biosynthesis II (plants),BioCyc
ARA:PLPSAL-PWY,1,0.9258295961265683,0,5,pyridoxal 5'-phosphate salvage I,BioCyc
ARA:POLYAMINSYN3-PWY,1,0.9485175472297409,0,3,superpathway of polyamine biosynthesis II,BioCyc
ARA:PROSYN-PWY,1,0.9495358345258577,0,3,L-proline biosynthesis I,BioCyc
ARA:PROUT-PWY,1,0.9380106311114524,0,4,L-proline degradation,BioCyc
ARA:PWY-1001,1,0.7705014462415186,0,20,cellulose biosynthesis,BioCyc
ARA:PWY-102,1,0.8474482702405406,0,9,gibberellin inactivation I (2&beta;-hydroxylation),BioCyc
ARA:PWY-1061,1,0.5997765954753433,0,29,homogalacturonan biosynthesis,BioCyc
ARA:PWY-1081,1,0.4975752173303075,0,38,homogalacturonan degradation,BioCyc
ARA:PWY-112,1,0.9310743410995354,0,5,lupeol biosynthesis,BioCyc
ARA:PWY-116,1,0.9278127280404492,0,4,coniferin metabolism,BioCyc
ARA:PWY-1186,1,0.8743200417223141,0,8,L-homomethionine biosynthesis,BioCyc
ARA:PWY-1187,1,0.5432943987476527,0,31,glucosinolate biosynthesis from homomethionine,BioCyc
ARA:PWY-1269,1,0.8568036735721941,0,9,CMP-3-deoxy-D-manno-octulosonate biosynthesis,BioCyc
ARA:PWY-1422,1,0.8483512717945795,0,9,vitamin E biosynthesis (tocopherols),BioCyc
ARA:PWY-1581,1,0.8891075300514344,0,6,plastoquinol-9 biosynthesis I,BioCyc
ARA:PWY-1722,1,0.8597594006136354,0,8,"formate assimilation into 5,10-methylenetetrahydrofolate",BioCyc
ARA:PWY-1801,1,0.9627127173204524,0,2,formaldehyde oxidation II (glutathione-dependent),BioCyc
ARA:PWY-1822,1,0.8721021328018953,0,7,indole-3-acetate activation I,BioCyc
ARA:PWY-1881,1,0.9827577999901002,0,1,formate oxidation to CO2,BioCyc
ARA:PWY-2,1,0.9563556873553075,0,3,putrescine degradation IV,BioCyc
ARA:PWY-2021,1,0.8363751128129496,0,10,indole-3-acetate degradation IV,BioCyc
ARA:PWY-2161B,1,0.8959122504210388,0,6,glutamate removal from folates,BioCyc
ARA:PWY-2161B-PMN,1,0.8504335184306504,0,10,folate polyglutamylation II,BioCyc
ARA:PWY-2181,1,0.9068628396879205,0,5,free phenylpropanoid acid biosynthesis,BioCyc
ARA:PWY-2301,1,0.8976968371299734,0,6,myo-inositol biosynthesis,BioCyc
ARA:PWY-2501,1,0.7982780184960288,0,15,fatty acid &alpha;-oxidation I,BioCyc
ARA:PWY-2582,1,0.8855178078583085,0,8,brassinosteroid biosynthesis II,BioCyc
ARA:PWY-2602,1,0.9776378444689618,0,1,brassinosteroid biosynthesis III,BioCyc
ARA:PWY-2681,1,0.7316511537470306,0,17,trans-zeatin biosynthesis,BioCyc
ARA:PWY-2724,1,0.8351119332923721,0,12,alkane oxidation,BioCyc
ARA:PWY-2781,1,0.9682699685145341,0,2,cis-zeatin biosynthesis,BioCyc
ARA:PWY-282,1,0.8625097750077424,0,8,cuticular wax biosynthesis,BioCyc
ARA:PWY-2821,1,0.6955629633918676,0,18,glucosinolate biosynthesis from phenylalanine,BioCyc
ARA:PWY-2841,1,0.8930347294957186,0,7,cytokinins degradation,BioCyc
ARA:PWY-2881,1,0.8686616741488219,0,7,cytokinins 7-N-glucoside biosynthesis,BioCyc
ARA:PWY-2901,1,0.8686616741488219,0,7,cytokinins 9-N-glucoside biosynthesis,BioCyc
ARA:PWY-2902,1,0.8592881647528772,0,8,cytokinin-O-glucosides biosynthesis,BioCyc
ARA:PWY-3001,1,0.5225551377596893,0,41,superpathway of L-isoleucine biosynthesis I,BioCyc
ARA:PWY-3041,1,0.9370388522605791,0,4,monoterpene biosynthesis,BioCyc
ARA:PWY-3101,1,0.7999335206322498,0,11,flavonol biosynthesis,BioCyc
ARA:PWY-3181,1,0.949450679886034,0,5,L-tryptophan degradation VI (via tryptamine),BioCyc
ARA:PWY-3221,1,0.979684545968796,0,1,dTDP-L-rhamnose biosynthesis II,BioCyc
ARA:PWY-3261,1,0.930862860715891,0,4,UDP-L-rhamnose biosynthesis,BioCyc
ARA:PWY-3301,1,0.5134855588999825,0,39,sinapate ester biosynthesis,BioCyc
ARA:PWY-3341,1,0.9349322026573245,0,4,L-proline biosynthesis III,BioCyc
ARA:PWY-3385,1,0.7914032134932735,0,14,choline biosynthesis I,BioCyc
ARA:PWY-3461,1,0.8460419950989495,0,9,L-tyrosine biosynthesis II,BioCyc
ARA:PWY-3462,1,0.7864249409529525,0,13,L-phenylalanine biosynthesis II,BioCyc
ARA:PWY-3481,1,0.7411760627624923,0,16,superpathway of L-phenylalanine and L-tyrosine biosynthesis,BioCyc
ARA:PWY-3561,1,0.7059555952223426,0,26,choline biosynthesis III,BioCyc
ARA:PWY-361,1,0.3629595220328555,0,54,phenylpropanoid biosynthesis,BioCyc
ARA:PWY-3742,1,0.5875581266353405,0,30,tetrahydrofolate biosynthesis II,BioCyc
ARA:PWY-3801,1,0.5500905539501117,0,41,sucrose degradation II (sucrose synthase),BioCyc
ARA:PWY-381,1,0.8008357879355539,0,13,nitrate reduction II (assimilatory),BioCyc
ARA:PWY-3821,1,0.8711315523427764,0,8,D-galactose degradation III,BioCyc
ARA:PWY-3881,1,0.87850477077789,0,7,mannitol biosynthesis,BioCyc
ARA:PWY-3982,1,0.9482699349008717,0,3,uracil degradation I (reductive),BioCyc
ARA:PWY-4,1,0.9604727958675966,0,3,UDP-D-galacturonate biosynthesis II (from D-galacturonate),BioCyc
ARA:PWY-40,1,0.95059886397243,0,3,putrescine biosynthesis I,BioCyc
ARA:PWY-4041,1,0.8281504287019419,0,11,&gamma;-glutamyl cycle,BioCyc
ARA:PWY-4081,1,0.7570576866264971,0,15,glutathione-peroxide redox reactions,BioCyc
ARA:PWY-4101,1,0.72988317293719,0,17,D-sorbitol degradation I,BioCyc
ARA:PWY-4203,1,0.9418068869515525,0,3,volatile benzenoid biosynthesis I (ester formation),BioCyc
ARA:PWY-4221ARA,1,0.7408287882256105,0,16,superpathway of pantothenate and coenzymeA biosynthesis,BioCyc
ARA:PWY-4261,1,0.9658031305165455,0,2,glycerol degradation I,BioCyc
ARA:PWY-43,1,0.8995670413070996,0,6,putrescine biosynthesis II,BioCyc
ARA:PWY-4302,1,0.18007918512118745,0,84,aerobic respiration III (alternative oxidase pathway),BioCyc
ARA:PWY-4321,1,0.8292098978741568,0,12,L-glutamate degradation IV,BioCyc
ARA:PWY-4341,1,0.9873313824964608,0,2,L-glutamate biosynthesis V,BioCyc
ARA:PWY-4361,1,0.6938583260121378,0,20,S-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation,BioCyc
ARA:PWY-4381,1,0.7987055496859093,0,14,fatty acid biosynthesis initiation I,BioCyc
ARA:PWY-4541,1,0.8380923178758178,0,9,"lipid-dependent phytate biosynthesis I (via Ins(1,4,5)P3)",BioCyc
ARA:PWY-4562,1,0.7620386234787958,0,15,"lipid-dependent phytate biosynthesis II (via Ins(1,3,4)P3)",BioCyc
ARA:PWY-4661,1,0.7867382532852834,0,14,1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza),BioCyc
ARA:PWY-4702,1,0.9301491557604871,0,4,phytate degradation I,BioCyc
ARA:PWY-4765,1,0.7620386234787958,0,15,superpathway of lipid-dependent phytate biosynthesis,BioCyc
ARA:PWY-4821,1,0.727618737656867,0,18,UDP-D-xylose biosynthesis,BioCyc
ARA:PWY-4841,1,0.8808233019741779,0,7,UDP-&alpha;-D-glucuronate biosynthesis (from myo-inositol),BioCyc
ARA:PWY-4861,1,0.8866259360131558,0,6,UDP-D-galacturonate biosynthesis I (from UDP-D-glucuronate),BioCyc
ARA:PWY-4983,1,0.9164516439943465,0,5,L-citrulline-nitric oxide cycle,BioCyc
ARA:PWY-4984,1,0.9009019574170548,0,6,urea cycle,BioCyc
ARA:PWY-5027,1,0.9202548168784676,0,4,phylloquinol biosynthesis,BioCyc
ARA:PWY-5032,1,0.9873465163200197,0,1,ent-kaurene biosynthesis I,BioCyc
ARA:PWY-5034,1,0.9357393519821601,0,4,GA12 biosynthesis,BioCyc
ARA:PWY-5035,1,0.7585148778591009,0,14,gibberellin biosynthesis III (early C-13 hydroxylation),BioCyc
ARA:PWY-5036,1,0.9593811846848185,0,2,gibberellin biosynthesis II (early C-3 hydroxylation),BioCyc
ARA:PWY-5041,1,0.7777003482206383,0,15,S-adenosyl-L-methionine cycle II,BioCyc
ARA:PWY-5043,1,0.7680352578032398,0,15,purine nucleosides salvage II (plant),BioCyc
ARA:PWY-5049,1,0.9790247105821861,0,1,rosmarinic acid biosynthesis II,BioCyc
ARA:PWY-5060,1,0.9250620860860396,0,4,luteolin biosynthesis,BioCyc
ARA:PWY-5070,1,0.8307851921624783,0,9,"gibberellin biosynthesis I (non C-3, non C-13 hydroxylation)",BioCyc
ARA:PWY-5083,1,0.2462387368106798,0,70,NAD/NADH phosphorylation and dephosphorylation,BioCyc
ARA:PWY-5097,1,0.735275737864381,0,19,L-lysine biosynthesis VI,BioCyc
ARA:PWY-5107,1,0.9610270681448533,0,2,phytol salvage pathway,BioCyc
ARA:PWY-5111,1,0.8753288148241505,0,8,CMP-KDO biosynthesis II (from D-arabinose 5-phosphate),BioCyc
ARA:PWY-5113,1,0.9663714473854289,0,2,UDP-D-apiose biosynthesis (from UDP-D-glucuronate),BioCyc
ARA:PWY-5114,1,0.49723060395999996,0,39,UDP-sugars interconversion,BioCyc
ARA:PWY-5115,1,0.9832482038799191,0,1,GDP-L-galactose biosynthesis,BioCyc
ARA:PWY-5120,1,0.7409503658904665,0,14,geranylgeranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5121,1,0.526637296977893,0,34,superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP),BioCyc
ARA:PWY-5122,1,0.719608722696689,0,16,geranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5125,1,0.8529800980223297,0,8,anthocyanin biosynthesis,BioCyc
ARA:PWY-5129,1,0.5742335303984186,0,32,sphingolipid biosynthesis (plants),BioCyc
ARA:PWY-5136,1,0.7988488536364393,0,14,fatty acid &beta;-oxidation II (peroxisome),BioCyc
ARA:PWY-5138,1,0.8295172339171265,0,10,"unsaturated, even numbered fatty acid &beta;-oxidation",BioCyc
ARA:PWY-5142,1,0.8945585162214343,0,6,acyl-ACP thioesterase pathway,BioCyc
ARA:PWY-5148,1,0.852893336099856,0,8,acyl-CoA hydrolysis,BioCyc
ARA:PWY-5152,1,0.8235294856578934,0,10,leucodelphinidin biosynthesis,BioCyc
ARA:PWY-5168,1,0.9307288742305061,0,4,ferulate and sinapate biosynthesis,BioCyc
ARA:PWY-5172,1,0.8807970409407457,0,8,acetyl-CoA biosynthesis III (from citrate),BioCyc
ARA:PWY-5175,1,0.9834119977611907,0,1,lactucaxanthin biosynthesis,BioCyc
ARA:PWY-5176,1,0.9853869381657903,0,1,coumarin biosynthesis (via 2-coumarate),BioCyc
ARA:PWY-5188,1,0.7934049299836899,0,13,tetrapyrrole biosynthesis I (from glutamate),BioCyc
ARA:PWY-5194,1,0.9110128834967046,0,5,siroheme biosynthesis,BioCyc
ARA:PWY-5269,1,0.8868471972109648,0,6,cardiolipin biosynthesis II,BioCyc
ARA:PWY-5285,1,0.9611659630299292,0,2,sulfide oxidation III (persulfide dioxygenase),BioCyc
ARA:PWY-5287,1,0.9803145636241256,0,1,sanguinarine and macarpine biosynthesis,BioCyc
ARA:PWY-5313,1,0.9202335685977692,0,4,superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside),BioCyc
ARA:PWY-5326,1,0.962937157028774,0,2,sulfite oxidation IV,BioCyc
ARA:PWY-5337,1,0.8152616956049444,0,12,stachyose biosynthesis,BioCyc
ARA:PWY-5340,1,0.8196479829471934,0,10,sulfate activation for sulfonation,BioCyc
ARA:PWY-5342,1,0.9866877601085036,0,1,ajugose biosynthesis I (galactinol-dependent),BioCyc
ARA:PWY-5343,1,0.9838921126243211,0,1,ajugose biosynthesis II (galactinol-independent),BioCyc
ARA:PWY-5350,1,0.8352881191345093,0,8,thiosulfate disproportionation IV (rhodanese),BioCyc
ARA:PWY-5366,1,0.8945585162214343,0,6,palmitoleate biosynthesis II (plants and bacteria),BioCyc
ARA:PWY-5377,1,0.9420947238989662,0,4,&alpha;-amyrin biosynthesis,BioCyc
ARA:PWY-5386,1,0.6785795230951207,0,22,methylglyoxal degradation I,BioCyc
ARA:PWY-5389,1,0.938150720848671,0,3,3-methylthiopropanoate biosynthesis,BioCyc
ARA:PWY-5391,1,0.8343936544565717,0,9,syringetin biosynthesis,BioCyc
ARA:PWY-5410,1,0.8652001945112375,0,8,traumatin and (Z)-3-hexen-1-yl acetate biosynthesis,BioCyc
ARA:PWY-5441,1,0.923431164147851,0,5,S-methyl-L-methionine cycle,BioCyc
ARA:PWY-5466,1,0.9447838050493776,0,3,matairesinol biosynthesis,BioCyc
ARA:PWY-5469,1,0.9589223960231772,0,2,sesamin biosynthesis,BioCyc
ARA:PWY-5481,1,0.9788644951691698,0,1,pyruvate fermentation to lactate,BioCyc
ARA:PWY-5530,1,0.8981972289268547,0,5,sorbitol biosynthesis II,BioCyc
ARA:PWY-561,1,0.5537090750476749,0,32,superpathway of glyoxylate cycle and fatty acid degradation,BioCyc
ARA:PWY-5640,1,0.9788118673301007,0,1,nitrobenzene degradation II,BioCyc
ARA:PWY-5659,1,0.732071860470933,0,20,GDP-mannose biosynthesis,BioCyc
ARA:PWY-5661,1,0.8046545838285788,0,16,GDP-glucose biosynthesis,BioCyc
ARA:PWY-5669,1,0.9320167460260023,0,5,phosphatidylethanolamine biosynthesis I,BioCyc
ARA:PWY-5686,1,0.9033788911868196,0,6,UMP biosynthesis I,BioCyc
ARA:PWY-5687,1,0.5180443519756409,0,38,pyrimidine ribonucleotides interconversion,BioCyc
ARA:PWY-5690,1,0.4755951558889075,0,41,TCA cycle II (plants and fungi),BioCyc
ARA:PWY-5691,1,0.941376475059978,0,3,urate degradation to allantoin I,BioCyc
ARA:PWY-5692,1,0.9678256042520839,0,2,allantoin degradation to glyoxylate II,BioCyc
ARA:PWY-5697,1,0.9685584352782112,0,2,allantoin degradation to ureidoglycolate I (urea producing),BioCyc
ARA:PWY-5698,1,0.9383961425142809,0,4,allantoin degradation to ureidoglycolate II (ammonia producing),BioCyc
ARA:PWY-5704,1,0.9883871816095733,0,1,urea degradation II,BioCyc
ARA:PWY-5723,1,0.47746167056518035,0,41,Rubisco shunt,BioCyc
ARA:PWY-5765,1,0.9298590129929014,0,4,"1,3,5-trimethoxybenzene biosynthesis",BioCyc
ARA:PWY-5783,1,0.9633610260360889,0,2,octaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-5788,1,0.8363751128129496,0,10,indole-3-acetate degradation V,BioCyc
ARA:PWY-5800,1,0.7883953957225747,0,14,xylan biosynthesis,BioCyc
ARA:PWY-5805,1,0.9633610260360889,0,2,nonaprenyl diphosphate biosynthesis I,BioCyc
ARA:PWY-5868,1,0.5940765635572292,0,28,simple coumarins biosynthesis,BioCyc
ARA:PWY-5871,1,0.8804615273845661,0,8,ubiquinol-9 biosynthesis (eukaryotic),BioCyc
ARA:PWY-5876,1,0.9640477169880787,0,2,magnoflorine biosynthesis,BioCyc
ARA:PWY-5884,1,0.6679309918160387,0,22,wax esters biosynthesis I,BioCyc
ARA:PWY-5886,1,0.9324374482014134,0,4,4-hydroxyphenylpyruvate biosynthesis,BioCyc
ARA:PWY-5905,1,0.9406250388532535,0,3,hypusine biosynthesis,BioCyc
ARA:PWY-5921,1,0.8514071424011908,0,9,glutaminyl-tRNAgln biosynthesis via transamidation,BioCyc
ARA:PWY-5934,1,0.795738739864684,0,14,iron reduction and absorption,BioCyc
ARA:PWY-5936,1,0.6169877482061794,0,26,xyloglucan biosynthesis,BioCyc
ARA:PWY-5943,1,0.9798596169805415,0,1,&beta;-carotene biosynthesis,BioCyc
ARA:PWY-5944,1,0.9805865025117456,0,1,zeaxanthin biosynthesis,BioCyc
ARA:PWY-5945,1,0.9332124034891083,0,4,"zeaxanthin, antheraxanthin and violaxanthin interconversion",BioCyc
ARA:PWY-5946,1,0.9834119977611907,0,1,&delta;-carotene biosynthesis,BioCyc
ARA:PWY-5947,1,0.9399496959446012,0,4,lutein biosynthesis,BioCyc
ARA:PWY-5957,1,0.9358076355401012,0,3,L-nicotianamine biosynthesis,BioCyc
ARA:PWY-5963,1,0.8388736568271499,0,11,thio-molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-5973,1,0.611687371389217,0,26,cis-vaccenate biosynthesis,BioCyc
ARA:PWY-5980,1,0.5476949083146478,0,33,xylogalacturonan biosynthesis,BioCyc
ARA:PWY-5986,1,0.9605109727456458,0,2,ammonium transport,BioCyc
ARA:PWY-5992,1,0.4567415187225135,0,42,thalianol and derivatives biosynthesis,BioCyc
ARA:PWY-5995,1,0.9476124519382668,0,3,linoleate biosynthesis I (plants),BioCyc
ARA:PWY-5997,1,0.9513003539723692,0,3,&alpha;-linolenate biosynthesis I (plants and red algae),BioCyc
ARA:PWY-5998,1,0.9771506186606113,0,1,&gamma;-linolenate biosynthesis I (plants),BioCyc
ARA:PWY-6,1,0.974399355710034,0,2,GDP-L-fucose biosynthesis II (from L-fucose),BioCyc
ARA:PWY-6005,1,0.9883178835764932,0,1,marneral biosynthesis,BioCyc
ARA:PWY-6007,1,0.9803031335788098,0,2,arabidiol biosynthesis,BioCyc
ARA:PWY-601,1,0.5503058242976243,0,30,glucosinolate biosynthesis from tryptophan,BioCyc
ARA:PWY-6012,1,0.9231054133413582,0,4,acyl carrier protein metabolism,BioCyc
ARA:PWY-6019,1,0.9287338596137816,0,4,pseudouridine degradation,BioCyc
ARA:PWY-6039,1,0.6626951155034226,0,21,chlorogenic acid biosynthesis I,BioCyc
ARA:PWY-6040,1,0.7884164254992166,0,12,chlorogenic acid biosynthesis II,BioCyc
ARA:PWY-6064,1,0.9613997603997123,0,2,methylquercetin biosynthesis,BioCyc
ARA:PWY-6066,1,0.9688894119708602,0,2,IAA biosynthesis VII,BioCyc
ARA:PWY-6115,1,0.8909128428703476,0,9,"avenacin biosynthesis, initial reactions",BioCyc
ARA:PWY-6118,1,0.8701611326321176,0,8,glycerol-3-phosphate shuttle,BioCyc
ARA:PWY-6121,1,0.8799404917971985,0,7,5-aminoimidazole ribonucleotide biosynthesis I,BioCyc
ARA:PWY-6122,1,0.8799404917971985,0,7,5-aminoimidazole ribonucleotide biosynthesis II,BioCyc
ARA:PWY-6124,1,0.9095428165492179,0,6,inosine-5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6132,1,0.9776353247337758,0,2,lanosterol biosynthesis,BioCyc
ARA:PWY-6137,1,0.9183156327337515,0,6,copper transport II,BioCyc
ARA:PWY-6147,1,0.8874014164944883,0,6,6-hydroxymethyl-dihydropterin diphosphate biosynthesis I,BioCyc
ARA:PWY-6164,1,0.9137674620466337,0,5,3-dehydroquinate biosynthesis I,BioCyc
ARA:PWY-6196,1,0.9599286644719612,0,2,D-serine metabolism,BioCyc
ARA:PWY-6199,1,0.8587027689358779,0,7,quercetin sulfate biosynthesis,BioCyc
ARA:PWY-621,1,0.6131977663084027,0,29,sucrose degradation III (sucrose invertase),BioCyc
ARA:PWY-6213,1,0.9339358579652357,0,6,cadmium transport I,BioCyc
ARA:PWY-6219,1,0.8363751128129496,0,10,indole-3-acetyl-amide conjugate biosynthesis,BioCyc
ARA:PWY-622,1,0.6491646022877248,0,33,starch biosynthesis,BioCyc
ARA:PWY-6220,1,0.9212329570944602,0,5,jasmonoyl-amino acid conjugates biosynthesis I,BioCyc
ARA:PWY-6232,1,0.9793301493864827,0,1,chrysoeriol biosynthesis,BioCyc
ARA:PWY-6233,1,0.9212329570944602,0,5,jasmonoyl-amino acid conjugates biosynthesis II,BioCyc
ARA:PWY-6235,1,0.9229717265911686,0,4,hydroxyjasmonate sulfate biosynthesis,BioCyc
ARA:PWY-6287,1,0.906914444452262,0,7,neurosporene biosynthesis,BioCyc
ARA:PWY-6295,1,0.9576012911639744,0,2,olivetol biosynthesis,BioCyc
ARA:PWY-63,1,0.830107557067623,0,11,UDP-L-arabinose biosynthesis I (from UDP-xylose),BioCyc
ARA:PWY-6303,1,0.9146189579965476,0,5,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY-6304,1,0.9277284606752781,0,4,casbene biosynthesis,BioCyc
ARA:PWY-6305,1,0.9319615553536237,0,4,putrescine biosynthesis IV,BioCyc
ARA:PWY-6317,1,0.806721351260074,0,15,D-galactose degradation I (Leloir pathway),BioCyc
ARA:PWY-6333,1,0.8076705214385764,0,12,acetaldehyde biosynthesis I,BioCyc
ARA:PWY-6351,1,0.45034378643843087,0,52,"D-myo-inositol (1,4,5)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6352,1,0.45103052203096045,0,63,3-phosphoinositide biosynthesis,BioCyc
ARA:PWY-6363,1,0.7369177947640931,0,20,"D-myo-inositol (1,4,5)-trisphosphate degradation",BioCyc
ARA:PWY-6364,1,0.8540446434788681,0,12,"D-myo-inositol (1,3,4)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6367,1,0.7888762965981759,0,14,D-myo-inositol-5-phosphate metabolism,BioCyc
ARA:PWY-6369,1,0.9060801765876213,0,7,inositol pyrophosphates biosynthesis,BioCyc
ARA:PWY-6406,1,0.9732714777360233,0,2,salicylate biosynthesis I,BioCyc
ARA:PWY-641,1,0.9270067587314734,0,4,proanthocyanidins biosynthesis from flavanols,BioCyc
ARA:PWY-6424,1,0.9583206311003509,0,2,"26,27-dehydrozymosterol metabolism",BioCyc
ARA:PWY-6441,1,0.8312568833805899,0,12,spermine and spermidine degradation III,BioCyc
ARA:PWY-6442,1,0.8994565550828784,0,5,spermidine hydroxycinnamic acid conjugates biosynthesis,BioCyc
ARA:PWY-6443,1,0.3459585871571047,0,54,"benzoate biosynthesis I (CoA-dependent, &beta;-oxidative)",BioCyc
ARA:PWY-6444,1,0.7985643013398784,0,15,"benzoate biosynthesis II (CoA-independent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6446,1,0.722600172327242,0,20,"benzoate biosynthesis III (CoA-dependent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6457,1,0.8656210511124819,0,8,trans-cinnamoyl-CoA biosynthesis,BioCyc
ARA:PWY-6466,1,0.8787611270365288,0,6,pyridoxal 5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6473,1,0.9619322308004673,0,3,4-aminobutanoate degradation IV,BioCyc
ARA:PWY-6475,1,0.8161739285125966,0,13,trans-lycopene biosynthesis II (plants),BioCyc
ARA:PWY-6483,1,0.8590722124921354,0,10,ceramide degradation,BioCyc
ARA:PWY-6498,1,0.8781045131536008,0,6,eumelanin biosynthesis,BioCyc
ARA:PWY-6502,1,0.9770236753411133,0,1,oxidized GTP and dGTP detoxification,BioCyc
ARA:PWY-6520,1,0.9335227810668558,0,4,nonaprenyl diphosphate biosynthesis II,BioCyc
ARA:PWY-6527,1,0.8199626402217867,0,13,stachyose degradation,BioCyc
ARA:PWY-6535,1,0.9619322308004673,0,3,4-aminobutanoate degradation I,BioCyc
ARA:PWY-6543,1,0.9102273745326036,0,5,4-aminobenzoate biosynthesis,BioCyc
ARA:PWY-6544,1,0.8452379706576751,0,11,superpathway of C28 brassinosteroid biosynthesis,BioCyc
ARA:PWY-6545,1,0.5791666922280747,0,29,pyrimidine deoxyribonucleotides de novo biosynthesis III,BioCyc
ARA:PWY-6546,1,0.8348466928564449,0,9,brassinosteroids inactivation,BioCyc
ARA:PWY-6549,1,0.5752261669095055,0,37,L-glutamine biosynthesis III,BioCyc
ARA:PWY-6554,1,0.7620386234787958,0,15,"1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)",BioCyc
ARA:PWY-6556,1,0.9396187530434141,0,3,pyrimidine ribonucleosides salvage II,BioCyc
ARA:PWY-6577,1,0.9499051583370823,0,3,farnesylcysteine salvage pathway,BioCyc
ARA:PWY-6596,1,0.7115213755759908,0,23,adenosine nucleotides degradation I,BioCyc
ARA:PWY-6599,1,0.9568621159421608,0,2,guanine and guanosine salvage II,BioCyc
ARA:PWY-66,1,0.8785342815743312,0,6,GDP-L-fucose biosynthesis I (from GDP-D-mannose),BioCyc
ARA:PWY-6605,1,0.8027800518598642,0,13,adenine and adenosine salvage II,BioCyc
ARA:PWY-6606,1,0.781662345382312,0,16,guanosine nucleotides degradation II,BioCyc
ARA:PWY-6612,1,0.8075974074834955,0,11,superpathway of tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6613,1,0.8564632182484998,0,8,"tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate",BioCyc
ARA:PWY-6614,1,0.8764280826522616,0,8,tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6619,1,0.9690826132086862,0,2,adenine and adenosine salvage VI,BioCyc
ARA:PWY-6623,1,0.940196412274748,0,3,salicylate glucosides biosynthesis II,BioCyc
ARA:PWY-6624,1,0.9586345385146325,0,2,salicylate glucosides biosynthesis III,BioCyc
ARA:PWY-6666,1,0.960312253550032,0,2,pyocyanin biosynthesis,BioCyc
ARA:PWY-6673,1,0.8476112334806171,0,9,caffeoylglucarate biosynthesis,BioCyc
ARA:PWY-6707,1,0.9854597091807716,0,1,gallate biosynthesis,BioCyc
ARA:PWY-6724,1,0.7962407166871308,0,15,starch degradation II,BioCyc
ARA:PWY-6730,1,0.9097673209971878,0,5,methylhalides biosynthesis (plants),BioCyc
ARA:PWY-6736,1,0.945929797629583,0,3,sulfur volatiles biosynthesis,BioCyc
ARA:PWY-6745,1,0.8674334026086012,0,8,phytochelatins biosynthesis,BioCyc
ARA:PWY-6754,1,0.8375037904053131,0,9,S-methyl-5'-thioadenosine degradation I,BioCyc
ARA:PWY-6756,1,0.8859877606963806,0,6,S-methyl-5'-thioadenosine degradation II,BioCyc
ARA:PWY-6762,1,0.9586345385146325,0,2,salicylate glucosides biosynthesis IV,BioCyc
ARA:PWY-6787,1,0.5816217287549865,0,27,flavonoid biosynthesis (in equisetum),BioCyc
ARA:PWY-6792,1,0.808679020120046,0,10,scopoletin biosynthesis,BioCyc
ARA:PWY-6799,1,0.9677714969910101,0,2,fatty acid biosynthesis (plant mitochondria),BioCyc
ARA:PWY-6802,1,0.9657423607640407,0,2,salidroside biosynthesis,BioCyc
ARA:PWY-6804,1,0.9175271091582113,0,5,diacylglycerol biosynthesis (PUFA enrichment in oilseed),BioCyc
ARA:PWY-6806,1,0.9505410308570769,0,3,carotenoid cleavage,BioCyc
ARA:PWY-6823,1,0.6918814694305757,0,20,molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-6825,1,0.8583050017859144,0,7,phosphatidylcholine biosynthesis V,BioCyc
ARA:PWY-6837,1,0.8103560798893807,0,12,"fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)",BioCyc
ARA:PWY-6845,1,0.9484784792433537,0,3,nitric oxide biosynthesis (plants),BioCyc
ARA:PWY-6898,1,0.8484830976211437,0,8,thiamine salvage III,BioCyc
ARA:PWY-6902,1,0.7247260652208571,0,15,chitin degradation II (Vibrio),BioCyc
ARA:PWY-6908,1,0.7985150163064096,0,11,thiamine diphosphate biosynthesis IV (eukaryotes),BioCyc
ARA:PWY-6909,1,0.9793800146375949,0,1,thiazole biosynthesis III (eukaryotes),BioCyc
ARA:PWY-6910,1,0.9825280133880859,0,1,hydroxymethylpyrimidine salvage,BioCyc
ARA:PWY-6922,1,0.8870231796055604,0,7,L-N&delta;-acetylornithine biosynthesis,BioCyc
ARA:PWY-6931,1,0.9911726843990458,0,1,seleno-amino acid detoxification and volatilization I,BioCyc
ARA:PWY-6932,1,0.9630377226414735,0,2,selenate reduction,BioCyc
ARA:PWY-6938,1,0.9684374626878118,0,2,NADH repair,BioCyc
ARA:PWY-695,1,0.8000630062111783,0,12,abscisic acid biosynthesis,BioCyc
ARA:PWY-6952,1,0.7434005460168805,0,18,glycerophosphodiester degradation,BioCyc
ARA:PWY-6959,1,0.7417495400799877,0,16,L-ascorbate degradation V,BioCyc
ARA:PWY-6963,1,0.8237904715283638,0,13,ammonia assimilation cycle I,BioCyc
ARA:PWY-6964,1,0.8290976320624918,0,12,ammonia assimilation cycle II,BioCyc
ARA:PWY-6982,1,0.7846477346332021,0,14,umbelliferone biosynthesis,BioCyc
ARA:PWY-699,1,0.8452379706576751,0,11,brassinosteroid biosynthesis I,BioCyc
ARA:PWY-701,1,0.9798172356548017,0,1,L-methionine degradation II,BioCyc
ARA:PWY-702,1,0.7438262722232362,0,18,L-methionine biosynthesis II,BioCyc
ARA:PWY-7039,1,0.4528742520634783,0,52,"phosphatidate metabolism, as a signaling molecule",BioCyc
ARA:PWY-7047,1,0.8756908601241724,0,7,malate-oxaloacetate shuttle I,BioCyc
ARA:PWY-7048,1,0.9073896582282376,0,5,malate-oxaloacetate shuttle II,BioCyc
ARA:PWY-7060,1,0.8906336150483073,0,7,ornithine-citrulline shuttle,BioCyc
ARA:PWY-7061,1,0.9252117055913415,0,6,glutamate-glutamine shuttle,BioCyc
ARA:PWY-7067,1,0.9195444894527987,0,4,betulinate biosynthesis,BioCyc
ARA:PWY-7068,1,0.9195444894527987,0,4,ursolate biosynthesis,BioCyc
ARA:PWY-7071,1,0.9582112608857213,0,2,steviol glucoside biosynthesis (rebaudioside A biosynthesis),BioCyc
ARA:PWY-7101,1,0.9434106356933509,0,3,5-deoxystrigol biosynthesis,BioCyc
ARA:PWY-7120,1,0.8902219686231223,0,6,esterified suberin biosynthesis,BioCyc
ARA:PWY-7140,1,0.9501019667892865,0,3,myricetin gentiobioside biosynthesis,BioCyc
ARA:PWY-7158,1,0.9609217783256587,0,2,L-phenylalanine degradation V,BioCyc
ARA:PWY-7170,1,0.9616516388973031,0,2,phytochromobilin biosynthesis,BioCyc
ARA:PWY-7176,1,0.600739273954991,0,29,UTP and CTP de novo biosynthesis,BioCyc
ARA:PWY-7177,1,0.7762655205792938,0,18,UTP and CTP dephosphorylation II,BioCyc
ARA:PWY-7183,1,0.853432073073977,0,11,pyrimidine nucleobases salvage I,BioCyc
ARA:PWY-7184,1,0.5256562664734616,0,35,pyrimidine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7185,1,0.6531387967957734,0,29,UTP and CTP dephosphorylation I,BioCyc
ARA:PWY-7186,1,0.7643519781034107,0,15,superpathway of scopolin and esculin biosynthesis,BioCyc
ARA:PWY-7187,1,0.6408656395707707,0,23,pyrimidine deoxyribonucleotides de novo biosynthesis II,BioCyc
ARA:PWY-7193,1,0.7872655741805556,0,16,pyrimidine ribonucleosides salvage I,BioCyc
ARA:PWY-7196,1,0.45431631556102847,0,47,superpathway of pyrimidine ribonucleosides salvage,BioCyc
ARA:PWY-7197,1,0.733470450361403,0,15,pyrimidine deoxyribonucleotide phosphorylation,BioCyc
ARA:PWY-7199,1,0.8161700402007966,0,11,pyrimidine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7200,1,0.5980555794818142,0,26,superpathway of pyrimidine deoxyribonucleoside salvage,BioCyc
ARA:PWY-7205,1,0.7346902306351585,0,15,CMP phosphorylation,BioCyc
ARA:PWY-7206,1,0.8683642413447051,0,7,pyrimidine deoxyribonucleotides dephosphorylation,BioCyc
ARA:PWY-7208,1,0.5120488026196148,0,40,superpathway of pyrimidine nucleobases salvage,BioCyc
ARA:PWY-7211,1,0.3426254835864885,0,61,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7213,1,0.885942014417775,0,7,wogonin metabolism,BioCyc
ARA:PWY-7219,1,0.43567108957661616,0,42,adenosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7221,1,0.6935110345331845,0,19,guanosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7224,1,0.7551010398486209,0,14,purine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7226,1,0.7890606542849943,0,12,guanosine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7227,1,0.7890606542849943,0,12,adenosine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7238,1,0.5762037516561944,0,39,sucrose biosynthesis II,BioCyc
ARA:PWY-724,1,0.5110618017054199,0,41,"superpathway of L-lysine, L-threonine and L-methionine biosynthesis II",BioCyc
ARA:PWY-7250,1,0.9801368421078305,0,1,[2Fe-2S] iron-sulfur cluster biosynthesis,BioCyc
ARA:PWY-7267,1,0.9202335685977692,0,4,anthocyanin biosynthesis (pelargonidin 3-O-glucoside),BioCyc
ARA:PWY-7270,1,0.45780525054042626,0,41,L-methionine salvage cycle II (plants),BioCyc
ARA:PWY-7325,1,0.9809597274119245,0,1,salvigenin biosynthesis,BioCyc
ARA:PWY-7343,1,0.842319568517776,0,14,UDP-glucose biosynthesis,BioCyc
ARA:PWY-7344,1,0.901220180057089,0,6,UDP-D-galactose biosynthesis,BioCyc
ARA:PWY-7346,1,0.9097575674461881,0,5,UDP-&alpha;-D-glucuronate biosynthesis (from UDP-glucose),BioCyc
ARA:PWY-735,1,0.651438662042719,0,25,jasmonic acid biosynthesis,BioCyc
ARA:PWY-7356,1,0.7695583459658929,0,13,thiamine salvage IV (yeast),BioCyc
ARA:PWY-7388,1,0.6024633191176807,0,30,"octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)",BioCyc
ARA:PWY-7398,1,0.6831670473818949,0,19,coumarins biosynthesis (engineered),BioCyc
ARA:PWY-7416,1,0.6033362789055741,0,27,"phospholipid remodeling (phosphatidylcholine, yeast)",BioCyc
ARA:PWY-7432,1,0.8141892546699145,0,11,"L-phenylalanine biosynthesis III (cytosolic, plants)",BioCyc
ARA:PWY-7436,1,0.9441874605587681,0,3,vitamin E biosynthesis (tocotrienols),BioCyc
ARA:PWY-7450,1,0.6086773036732198,0,25,anthocyanidin modification (Arabidopsis),BioCyc
ARA:PWY-7468,1,0.9586345385146325,0,2,benzoyl-&beta;-D-glucopyranose biosynthesis,BioCyc
ARA:PWY-7528,1,0.5773540119976234,0,28,L-methionine salvage cycle I (bacteria and plants),BioCyc
ARA:PWY-7560,1,0.7583884294536744,0,17,methylerythritol phosphate pathway II,BioCyc
ARA:PWY-7590,1,0.9477092249498628,0,3,"(7Z,10Z,13Z)-hexadecatrienoate biosynthesis",BioCyc
ARA:PWY-762,1,0.8424732642514186,0,9,phospholipid desaturation,BioCyc
ARA:PWY-7625,1,0.9206211814643572,0,5,phosphatidylinositol biosynthesis II (eukaryotes),BioCyc
ARA:PWY-782,1,0.8469468753907914,0,9,glycolipid desaturation,BioCyc
ARA:PWY-7985,1,0.9474014525129616,0,3,oxalate degradation VI,BioCyc
ARA:PWY-801,1,0.9150330784738776,0,5,L-homocysteine and L-cysteine interconversion,BioCyc
ARA:PWY-82,1,0.9677194151465053,0,3,UDP-L-arabinose biosynthesis II (from L-arabinose),BioCyc
ARA:PWY-83,1,0.9799711375761722,0,1,monolignol glucosides biosynthesis,BioCyc
ARA:PWY-84,1,0.9576012911639744,0,2,resveratrol biosynthesis,BioCyc
ARA:PWY-841,1,0.7890606542849943,0,12,superpathway of purine nucleotides de novo biosynthesis I,BioCyc
ARA:PWY-882,1,0.6497670916212107,0,26,L-ascorbate biosynthesis I (L-galactose pathway),BioCyc
ARA:PWY-922,1,0.7285323233543081,0,20,mevalonate pathway I,BioCyc
ARA:PWY0-1021,1,0.9475792826254852,0,3,L-alanine biosynthesis III,BioCyc
ARA:PWY0-1182,1,0.8848675975269147,0,8,trehalose degradation II (trehalase),BioCyc
ARA:PWY0-1264,1,0.8763470723785125,0,10,biotin-carboxyl carrier protein assembly,BioCyc
ARA:PWY0-1319,1,0.7995748988236216,0,13,CDP-diacylglycerol biosynthesis II,BioCyc
ARA:PWY0-1325,1,0.9144328578013097,0,6,superpathway of L-asparagine biosynthesis,BioCyc
ARA:PWY0-1507,1,0.8405101329027453,0,10,biotin biosynthesis from 8-amino-7-oxononanoate I,BioCyc
ARA:PWY0-1535,1,0.9599286644719612,0,2,D-serine degradation,BioCyc
ARA:PWY0-162,1,0.5422607177796352,0,35,superpathway of pyrimidine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY0-166,1,0.6095455418333269,0,26,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli),BioCyc
ARA:PWY0-461,1,0.9052232926337073,0,5,L-lysine degradation I,BioCyc
ARA:PWY0-501,1,0.8820417515582898,0,6,lipoate biosynthesis and incorporation I,BioCyc
ARA:PWY0-541,1,0.9529359854441218,0,4,cyclopropane fatty acid (CFA) biosynthesis,BioCyc
ARA:PWY0-662,1,0.8656686577804904,0,8,PRPP biosynthesis I,BioCyc
ARA:PWY0A-6303,1,0.7758623311052131,0,13,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY1F-353,1,0.9545617577197583,0,3,glycine betaine biosynthesis III (plants),BioCyc
ARA:PWY1F-467,1,0.9384657452673506,0,4,"phenylpropanoid biosynthesis, initial reactions",BioCyc
ARA:PWY1F-823,1,0.9230050361465316,0,4,leucopelargonidin and leucocyanidin biosynthesis,BioCyc
ARA:PWY1F-FLAVSYN,1,0.5368846730604638,0,33,flavonoid biosynthesis,BioCyc
ARA:PWY3DJ-35471,1,0.9296018249201637,0,4,L-ascorbate biosynthesis IV,BioCyc
ARA:PWY3O-450,1,0.8284472944111823,0,11,phosphatidylcholine biosynthesis I,BioCyc
ARA:PWY490-4,1,0.9267350496798353,0,4,L-asparagine biosynthesis III (tRNA-dependent),BioCyc
ARA:PWY4FS-10,1,0.9596286606184157,0,2,scopolin biosynthesis,BioCyc
ARA:PWY4FS-11,1,0.9393192153188389,0,4,L-ascorbate biosynthesis II (L-gulose pathway),BioCyc
ARA:PWY4FS-12,1,0.966120987530405,0,2,VTC2 cycle,BioCyc
ARA:PWY4FS-13,1,0.966120987530405,0,2,extended VTC2 cycle,BioCyc
ARA:PWY4FS-2,1,0.7878227654702038,0,15,phosphatidylcholine biosynthesis II,BioCyc
ARA:PWY4FS-3,1,0.8598336414352197,0,9,phosphatidylcholine biosynthesis III,BioCyc
ARA:PWY4FS-4,1,0.8598336414352197,0,9,phosphatidylcholine biosynthesis IV,BioCyc
ARA:PWY4FS-5,1,0.7120143548962387,0,20,superpathway of phosphatidylcholine biosynthesis,BioCyc
ARA:PWY4FS-6,1,0.8015387457830249,0,13,phosphatidylethanolamine biosynthesis II,BioCyc
ARA:PWY4FS-7,1,0.736826249941544,0,17,phosphatidylglycerol biosynthesis I (plastidic),BioCyc
ARA:PWY66-423,1,0.9102436225705329,0,5,"fructose 2,6-bisphosphate biosynthesis",BioCyc
ARA:PWYDQC-4,1,0.8792284717709462,0,7,indole-3-acetate biosynthesis I,BioCyc
ARA:PWYQT-1,1,0.9290027162378088,0,6,lysine degradation III,BioCyc
ARA:PWYQT-4427,1,0.9529988214929032,0,3,sulfoquinovosyl diacylglycerol biosynthesis,BioCyc
ARA:PWYQT-4429,1,0.9179365147459884,0,7,CO2 fixation into oxaloacetate (anaplerotic),BioCyc
ARA:PWYQT-4432,1,0.9154699182105676,0,5,glutathione degradation,BioCyc
ARA:PWYQT-4433,1,0.9345890366773728,0,4,CA1P biosynthesis,BioCyc
ARA:PWYQT-4445,1,0.7057640944543353,0,23,pyrimidine salvage pathway,BioCyc
ARA:PWYQT-4449,1,0.7153691148663583,0,16,polyisoprenoid biosynthesis,BioCyc
ARA:PWYQT-4450,1,0.8593222622770375,0,9,"aliphatic glucosinolate biosynthesis, side chain elongation cycle",BioCyc
ARA:PWYQT-4466,1,0.42684413437280166,0,54,superpathway of sucrose and starch metabolism I (non-photosynthetic tissue),BioCyc
ARA:PWYQT-4470,1,0.9477774500120021,0,4,&gamma;-glutamyl cycle (plant pathway),BioCyc
ARA:PWYQT-4472,1,0.6215545828131208,0,25,glucosinolate biosynthesis from trihomomethionine,BioCyc
ARA:PWYQT-4473,1,0.6215545828131208,0,25,glucosinolate biosynthesis from tetrahomomethionine,BioCyc
ARA:PWYQT-4474,1,0.6215545828131208,0,25,glucosinolate biosynthesis from pentahomomethionine,BioCyc
ARA:PWYQT-4475,1,0.5586432775650805,0,31,glucosinolate biosynthesis from hexahomomethionine,BioCyc
ARA:PWYQT-4477,1,0.7273251498177403,0,16,indole glucosinolate activation (intact plant cell),BioCyc
ARA:PWYQT-4481,1,0.4560006639298553,0,44,TCA cycle variation V (plant),BioCyc
ARA:PWYQT-4482,1,0.8483525680872442,0,9,CDP-diacylglycerol biosynthesis IV,BioCyc
ARA:PWYQT-62,1,0.557819614612486,0,33,superpathway of proto- and siroheme biosynthesis,BioCyc
ARA:PWYQT-94,1,0.7225847809327915,0,17,superpathway of polyamine biosynthesis,BioCyc
ARA:PYRIDNUCSYN-PWY,1,0.8876000614527056,0,7,NAD biosynthesis I (from aspartate),BioCyc
ARA:RIBOSYN2-PWY,1,0.7852379285653481,0,14,flavin biosynthesis I (bacteria and plants),BioCyc
ARA:SAM-PWY,1,0.870936086713557,0,7,S-adenosyl-L-methionine biosynthesis,BioCyc
ARA:SERSYN-PWY,1,0.896470607976964,0,6,L-serine biosynthesis,BioCyc
ARA:THIOREDOX-PWY,1,0.6613145604602616,0,19,thioredoxin pathway,BioCyc
ARA:THRESYN-PWY,1,0.6426784496228664,0,28,superpathway of L-threonine biosynthesis,BioCyc
ARA:TRESYN-PWY,1,0.6617947272041135,0,28,trehalose biosynthesis I,BioCyc
ARA:TYRFUMCAT-PWY,1,0.7680707080353817,0,14,L-tyrosine degradation I,BioCyc
ARA:UDPNACETYLGALSYN-PWY,1,0.8733906851662416,0,8,UDP-N-acetyl-D-glucosamine biosynthesis II,BioCyc
ARA:VALSYN-PWY,1,0.7750059561924221,0,17,L-valine biosynthesis,BioCyc
ARA:XYLCAT-PWY,1,0.9399743513357621,0,4,xylose degradation I,BioCyc
ARA:PWY-5123,1.0000000000000053,0.6657859062339934,0,21,"trans, trans-farnesyl diphosphate biosynthesis",BioCyc
